THE RETURN OF SYPHILIS
Jeff Childers
In addition to shortages of the attention-focusing drug Adderall, two more common, critically-necessary drugs confoundingly dropped into shortage status last month. Becker’s Hospital Review ran a story headlined, “Common Penicillin Type In Shortage.”
On April 26th, the FDA added penicillin G benzathine (PenG) to its drug shortages list. PenG is the standard treatment for the body-rotting STD, syphilis. PenG is also commonly used to treat bad cases of strep throat.
Why the shortage? Did the PenG factory burn down or something? Nope. “The FDA believes the demand increase of this drug is related to the increased cases of strep throat and syphilis in the U.S.,” the agency said. The U.S. saw a significant increase in syphilis infections during the pandemic, with more than 176,000 new cases reported in 2021 — a 70-year high.
2021. Huh. What else happened in 2021?
Syphilis in this country was well under control, with cases reaching historic lows over twenty years ago. The Becker article stressed that the horrible disease is now not only spreading among gays. The CDC said syphilis is also rising among straight men and women across all U.S. regions and all age groups.
Syphilis and strep breakouts. What on Earth could the common factor be?
These new epidemics of old diseases are showing no signs ending anytime soon. Leandro Mena, MD, director of the CDC’s Division of STD Prevention, agrees, saying “The U.S. STD epidemic shows no signs of slowing.” And of course, scientists are baffled: “The reasons for the ongoing increases are multifaceted — and so are the solutions. For the first time in decades, we’re seeing promising new STD interventions on the horizon, but these alone will not solve this epidemic,” Mena explained.
An epidemic of STDs! It’s like a horde of locusts, except worse.
Also buried in the article was the admission of ANOTHER common drug shortage: “A months’ long shortage of amoxicillin, another antibiotic used to treat strep, has caused frustration for patients, physicians and pharmacists amid the strep uptick.“
A strep epidemic and shortages of amoxicillin AND penicillin. What could go wrong? And unlike the covid pandemic, we’re not hearing much about about these new epidemics in corporate media.
When did corporate media lose its voracious appetite for disease news?
I won’t beat around the bush. Since the scientists are baffled, I might as well speculate: I wonder whether all these common drugs going into shortage are being used up by massive numbers of people treated for jab injuries. I wonder if we can see jab injury statistics in the levels of consumption of OTHER drugs.
Adderall, for example, treats brain fog — a mild neurological injury. Antibiotics treat STD’s, streptococcus, and other opportunistic bugs now infecting large numbers of people, people whose bodies USED to be able to fight off these common illnesses.
In other words, an epidemic of immunosuppression is leading to an epidemic of unrelated secondary infections, which are using up drug supplies. Ethical Skeptic has been tracking cancer drug prescriptions and they are also skyrocketing. The CDC won’t be able to hide this forever.
In the meantime, even though the ravages of monkeypox appear to be under control, with syphilis now at epidemic levels, you might want to consider ratcheting back your festival plans this year.
So.
Good timing of this article given I had come across that video from Jane Ruby yesterday where she was reporting that a group of researchers had identified genetic additions to the vaccinations that would cause injectees to suffer form antibiotic resistance. This story might be confirming that as secondary evidence. Because what do Docs do when an antibiotic seems ineffective? Well they start by increasing the dosage. That would push up demand of course and could result in shortages if there were enough new infections all at once. Lets keep adding up two plus two here. What is the problem….then what is the reaction and finally the outcome.